Generate a tailored SOP for Dr. Stanley Liu. Improve your application with a focused, well-structured draft.
Stanley Liu is an Associate Professor in the Department of Radiation Oncology and the Department of Medical Biophysics at the University of Toronto, as well as a Clinician-Scientist at the Sunnybrook Health Sciences Centre. He specializes in prostate cancer, focusing on non-coding RNA and its role in tumor treatment response. His research explores the expression patterns of microRNAs and their influence on the effectiveness of anti-cancer therapies, particularly in the context of radiotherapy. Liu's work has demonstrated that miR-95 promotes tumor radiation resistance and has identified SGPP1 as a novel target of this microRNA. He is investigating microRNA biomarkers for cancer detection and management, emphasizing the potential of urinary microRNAs as non-invasive predictive biomarkers for aggressive forms of prostate cancer. His lab is also researching innovative methods to protect normal tissue during radiotherapy, aiming to minimize treatment-related toxicity and enhance patient quality of life. Liu is dedicated to advancing strategies that allow early identification of patients with aggressive prostate cancer to inform treatment decisions.
University of Toronto • Toronto, Ontario, Canada
Sunnybrook Health Sciences Centre • Toronto, Ontario, Canada
Department of Radiation Oncology, Sunnybrook • Toronto, Ontario, Canada
Biological Sciences – Odette Cancer Research Program, Sunnybrook Research Institute • Toronto, Ontario, Canada
Department of Sociology